Clinical Trial Update: Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating individualized immunosuppression guided by immune function monitoring in de novo renal transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: University Hospital, Ghent | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED